Zhou, Jianfang – Trademark Portfolio
Entity Type: 01
Zhou, Jianfang owns a portfolio of 23 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as CALMIO, ASIPEKY, RESTICA, VAVEDIC, and ATTQERTA. Of these, 13 are registered and 2 are pending. The portfolio spans 9 Nice Classification classes, led by Class 20 (Furniture) and Class 10 (Medical Apparatus). Headquartered in Lianyungang, Jiangsu.
No.54 Tangzhuang, Fangzhuang Vil.,
Yangji Town, Guanyun County,
Lianyungang, Jiangsu 222200 , CN
Showing of trademarks Trademarks
Trademark Classifications
Zhou, Jianfang's trademark portfolio spans 9 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Zhou, Jianfang have?
Zhou, Jianfang has 23 U.S. trademarks filed with the USPTO. Of these, 13 registered, 2 pending, 8 abandoned.
What trademark classes does Zhou, Jianfang file in?
Zhou, Jianfang files trademarks across 9 Nice Classification classes. The most active classes are Class 20 (Furniture), Class 10 (Medical Apparatus), Class 24 (Fabrics), Class 11 (Environmental Control), Class 25 (Clothing). Class 20 covers furniture, mirrors, picture frames; goods of wood, cork, reed, cane, wicker.
What are Zhou, Jianfang's most well-known trademarks?
Zhou, Jianfang's registered trademark portfolio includes well-known marks such as CALMIO, ASIPEKY, RESTICA, VAVEDIC, and ATTQERTA. These are among 13 currently registered trademarks in the portfolio.
What is Zhou, Jianfang's trademark registration success rate?
Zhou, Jianfang has a 62% trademark registration rate, with 13 out of 21 resolved applications resulting in successful registration. Currently, 2 applications are pending review.